| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―04 |
SARS-CoV-2 Mpro oligomerization as a potential target for therapy |
Kinga Lis, Jacek Plewka, Filipe Menezes, Ewa Bielecka, Yuliya Chykunova, Katarzyna Pustelny, Stephan Niebling, Angelica Struve Garcia, Maria Garcia-Alai, Grzegorz M. Popowicz, Anna Czarna, Tomasz Kantyka, Krzysztof Pyrc |
| 2 |
[GO] |
2024―Apr―03 |
An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review |
S. Moneshwaran, D. Macrin, N. Kanagathara |
| 3 |
[GO] |
2024―Mar―24 |
A comprehensive analysis of SARS-CoV-2 missense mutations indicates that all possible amino acid replacements in the viral proteins occurred within the first two-and-a-half years of the pandemic |
Nicole Balasco, Gianluca Damaggio, Luciana Esposito, Vincenza Colonna, Luigi Vitagliano |
| 4 |
[GO] |
2024―Mar―19 |
Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach |
Sabina Yasmin, Mohmmad Yousuf Ansari, Krishna Pandey, Manas Ranjan Dikhit |
| 5 |
[GO] |
2024―Mar―15 |
Antigenicity, epitope mapping, and intracellular distribution of the NSP7α protein of porcine reproductive and respiratory syndrome virus |
Tao Wang, Da-Song Xia, Xiao-Xiao Tian, Yong-Bo Yang, Tong-Qing An |
| 6 |
[GO] |
2024―Mar―12 |
Self-assembled ferritin-based nanoparticles elicit a robust broad-spectrum protective immune response against SARS-CoV-2 variants |
Weiqi Wang, Xianyong Meng, Huan Cui, Cheng Zhang, Shen Wang, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Xianzhu Xia |
| 7 |
[GO] |
2024―Mar―11 |
Characterization of chitosan/Persian gum nanoparticles for encapsulation of Nigella sativa extract as an antiviral agent against avian coronavirus |
Mohammad Hadian, Morteza Fathi, Ali Mohammadi, Mohammad Hadi Eskandari, Mehdi Asadsangabi, Khadijeh Pouraghajan, Majid Shohrati, Masoomeh Mohammadpour, Mohammad Samadi |
| 8 |
[GO] |
2024―Mar―08 |
An allosteric mechanism for potent inhibition of SARS-CoV-2 main proteinase |
Yunju Zhang, Jingjing Guo, Yang Liu, Yuanyuan Qu, Yong-Qiang Li, Yuguang Mu, Weifeng Li |
| 9 |
[GO] |
2024―Mar―07 |
pGM-CSF as an adjuvant in DNA vaccination against SARS-CoV-2 |
Chang Liu, Ruo-Yi Xue, Guo-Cheng Li, Yi Zhang, Wei-Yi Wu, Jing-Yi Liu, Rang Feng, Zhe Jin, Yan Deng, Zi-Li Jin, Hao Cheng, Ling Mao, Quan-Ming Zou, Hai-Bo Li |
| 10 |
[GO] |
2024―Feb―21 |
Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors |
Feng Wang, Donglan Liu, Dingding Gao, Jinwei Yuan, Jingxian Zhao, Shuai Yuan, Yixin Cen, Guo-Qiang Lin, Jincun Zhao, Ping Tian |
| 11 |
[GO] |
2024―Feb―12 |
Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins |
Daniel Polo-Megías, Mario Cano-Muñoz, Alberto G. Berruezo, Géraldine Laumond, Christiane Moog, Francisco Conejero-Lara |
| 12 |
[GO] |
2024―Feb―10 |
MD simulations indicate Omicron P132H of SARS-CoV-2 Mpro is a potential allosteric ymutant involved in modulating the dynamics of catalytic site entry loop |
Zahoor Ahmad Bhat, Mohd Muzammil Khan, Ayyub Rehman, Jawed Iqbal, B.S. Sanjeev, Arumugam Madhumalar |
| 13 |
[GO] |
2024―Feb―06 |
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines |
Sara Feola, Jacopo Chiaro, Manlio Fusciello, Salvatore Russo, Iivari Kleino, Leena Ylösmäki, Eliisa Kekäläinen, Johanna Hastbacka, Pirkka T. Pekkarinen, Erkko Ylösmäki, Stefania Capone, Antonella Folgori, Angelo Raggioli, Carolina Boni, Camilla Tezzi, Andrea Vecchi, Monica Gelzo, Hassen Kared, Alessandra Nardin, Michael Fehlings, Veronique Barban, Petra Ahokas, Tapani Viitala, Giuseppe Castaldo, Lucio Pastore, Paul Porter, Sari Pesonen, Vincenzo Cerullo |
| 14 |
[GO] |
2024―Jan―27 |
Inhibition of multiple SARS-CoV-2 variants entry by Lycium barbarum L. polysaccharides through disruption of spike protein-ACE2 interaction |
Jingxuan Li, Feng Liu, Fushan Wu, Xiaoyue Su, Lihui Zhang, Xueru Zhao, Chao Shang, Lu Han, Yongxiang Zhang, Zhiyong Xiao, Wenxia Zhou |
| 15 |
[GO] |
2024―Jan―22 |
Identification of antiviral phytochemicals from cranberry as potential inhibitors of SARS-CoV-2 main protease (Mpro) |
U. Jisha Pillai, Lucy Cherian, Khushman Taunk, Eldhose Iype, Mainak Dutta |
| 16 |
[GO] |
2024―Jan―15 |
Overview of the SARS-CoV-2 nucleocapsid protein |
Ahmed Eltayeb, Faisal Al-Sarraj, Mona Alharbi, Raed Albiheyri, Ehab Mattar, Isam M. Abu Zeid, Thamer A. Bouback, Atif Bamagoos, Bassam O. Aljohny, Vladimir N. Uversky, Elrashdy M. Redwan |
| 17 |
[GO] |
2024―Jan―09 |
A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19 |
Daohong Zhang, Deepak Kukkar, Ki-Hyun Kim, Poornima Bhatt |
| 18 |
[GO] |
2023―Dec―28 |
Severe acute respiratory syndrome Coronavirus-2 GenoAnalyzer and mutagenic anomaly detector using FCMFI and NSCE |
Shivendra Dubey, Dinesh Kumar Verma, Mahesh Kumar |
| 19 |
[GO] |
2023―Dec―28 |
Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD |
Zizhe An, Changkai Bu, Deling Shi, Qingqing Chen, Bin Zhang, Qingchi Wang, Lan Jin, Lianli Chi |
| 20 |
[GO] |
2023―Dec―22 |
Multivalent nanobody-based sandwich enzyme-linked immunosorbent assay for sensitive detection of porcine reproductive and respiratory syndrome virus |
Mingxia Sun, Yue Sun, Yongbo Yang, Man Zhao, Dan Cao, Minmin Zhang, Dasong Xia, Tao Wang, Yanfei Gao, Shanghui Wang, Haiwei Wang, Xuehui Cai, Tongqing An |
| 21 |
[GO] |
2023―Dec―17 |
Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2 |
Muhammad Waqas, Saeed Ullah, Sobia Ahsan Halim, Najeeb Ur Rehman, Amjad Ali, Afnan Jan, Abdullatif Bin Muhsinah, Ajmal Khan, Ahmed Al-Harrasi |
| 22 |
[GO] |
2023―Dec―07 |
Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity |
Ruyu Wang, Xuwen Chen, Hongtao Li, Xixiang Chen, Donghui Sun, Danmei Yu, Jiani Lu, Yuanyuan Xie, Qian Zhang, Jianrong Xu, Weidong Zhang, Hongzhuan Chen, Shunying Liu, Lili Chen |
| 23 |
[GO] |
2023―Nov―22 |
Structure-guided design of a trivalent nanobody cluster targeting SARS-CoV-2 spike protein |
Xinyi Jiang, Qin Qin, Haixia Zhu, Jiaqiang Qian, Qiang Huang |
| 24 |
[GO] |
2023―Nov―08 |
Lipid and cholesterols modulate the dynamics of SARS-CoV-2 viral ion channel ORF3a and its pathogenic variants |
Madhusmita Rout, Sarbani Mishra, Sunita Panda, Budheswar Dehury, Sanghamitra Pati |
| 25 |
[GO] |
2023―Oct―15 |
Dauricine interferes with SARS-CoV-2 variants infection by blocking the interface between RBD and ACE2 |
Lei Xie, Sai Shi, Lin Cheng, Binghong Xu, Sen Ma, Jie Liu, Xilin Wu, Yaxin Wang, Sheng Ye |
| 26 |
[GO] |
2023―Oct―13 |
Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2 |
Sumera Zaib, Nehal Rana, Hafiz Saqib Ali, Nadia Hussain, Hanan A. Ogaly, Fatimah A.M. Al-Zahrani, Imtiaz Khan |
| 27 |
[GO] |
2023―Oct―09 |
Codon usage bias analysis of the spike protein of human coronavirus 229E and its host adaptability |
Meng Lu, Wenbo Wan, Yuxing Li, Haipeng Li, Bowen Sun, Kang Yu, Jin Zhao, Giovanni Franzo, Shuo Su |
| 28 |
[GO] |
2023―Sep―29 |
A SARS-CoV-2 nanoparticle vaccine based on chemical conjugation of loxoribine and SpyCatcher/SpyTag |
Wenying Yan, Weili Yu, Lijuan Shen, Lucheng Xiao, Jinming Qi, Tao Hu |
| 29 |
[GO] |
2023―Sep―27 |
Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics |
Jessica Gasparello, Marco Verona, Adriana Chilin, Roberto Gambari, Giovanni Marzaro |
| 30 |
[GO] |
2023―Sep―12 |
Effects of the glycosylation of the receptor binding domain (RBD dimer)-based Covid-19 vaccine (ZF2001) on its humoral immunogenicity and immunoreactivity |
Xueqing Wang, Lulu Shi, Yirong Wang, Jia Chen, Zelan Yang, Chenglong Liu, Xiaomei Liu, Yang Li, Can Zhang, Anhui Sun, Huan Yan, Hui Sun |
| 31 |
[GO] |
2023―Sep―09 |
An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and its' most variants |
Weihong Zeng, Xiaoying Jia, Xiangyang Chi, Xinghai Zhang, Entao Li, Yan Wu, Yang Liu, Jin Han, Kang Ni, Xiaodong Ye, Xiaowen Hu, Huan Ma, Changming Yu, Sandra Chiu, Tengchuan Jin |
| 32 |
[GO] |
2023―Aug―02 |
Mutation and codon bias analysis of the spike protein of omicron, the recent variant of SARS-COV-2 |
Yunbiao Lu, Weixiu Wang, Hao Liu, Yue Li, Yan Ge, Giovanni Franzo, Jianjun Dai, Wan-Ting He |
| 33 |
[GO] |
2023―Jul―26 |
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants |
Lidong Wang, Yang Wang, Hao Zhou |
| 34 |
[GO] |
2023―Jul―23 |
Deciphering the role of fucoidan from brown macroalgae in inhibiting SARS-CoV-2 by targeting its main protease and receptor binding domain: Invitro and insilico approach |
Nidhi Hans, Shreya Gupta, Ashok Kumar Patel, Satyanarayan Naik, Anushree Malik |
| 35 |
[GO] |
2023―Jul―10 |
Three-dimensional porous wood monolithic columns for efficient purification of spike glycoprotein of SARS-CoV-2 |
Yuting Ren, Peng Ye, Limei Zhang, Jingyang Zhao, Jing Liu, Jiandu Lei, Luying Wang |
| 36 |
[GO] |
2023―Jul―07 |
Synthesis of multivalent sialyllactose-conjugated PAMAM dendrimers: Binding to SARS-CoV-2 spike protein and influenza hemagglutinin |
Peng He, Ke Xia, Yuefan Song, Ritesh Tandon, Rudra Channappanavar, Fuming Zhang, Robert J. Linhardt |
| 37 |
[GO] |
2023―Jul―03 |
Synthesis and characterization of n-phosphonium chitosan and its virucidal activity evaluation against coronavirus |
Celso Fidelis de Moura Junior, Deise Ochi, Emanuelle Dantas Freitas, Jonas Kerwald, Marcos Akira d'Ávila, Marisa Masumi Beppu |
| 38 |
[GO] |
2023―Jun―24 |
Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats |
Esmail M. El-Fakharany, Hamada El-Gendi, Yousra A. El-Maradny, Marwa M. Abu-Serie, Khaled G. Abdel-Wahhab, Marwa E. Shaban, Mahmoud Ashry |
| 39 |
[GO] |
2023―Jun―07 |
Eco-friendly and effective antimicrobial Melaleuca alternifolia essential oil Pickering emulsions stabilized with cellulose nanofibrils against bacteria and SARS-CoV-2 |
Greiciele da S. Ferreira, Daniel J. da Silva, Alana G. Souza, Eliana D.C. Yudice, Ivana B. de Campos, Rute Dal Col, Andre Mourão, Herculano S. Martinho, Derval S. Rosa |
| 40 |
[GO] |
2023―Jun―03 |
Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction |
Chaojie Wang, Fengming He, Ke Sun, Kaiqiang Guo, Sheng Lu, Tong Wu, Xiang Gao, Meijuan Fang |
| 41 |
[GO] |
2023―Jun―01 |
How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics? |
Jameel M. Abduljalil, Ahmed M. Elghareib, Ahmed Samir, Ahmed A. Ezat, Abdo A. Elfiky |
| 42 |
[GO] |
2023―May―17 |
A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough |
Manojit Bhattacharya, Abdulrahman Alshammari, Metab Alharbi, Kuldeep Dhama, Sang-Soo Lee, Chiranjib Chakraborty |
| 43 |
[GO] |
2023―May―11 |
Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 MPro and PLPro |
Bhavita Kattula, Bharati Reddi, Aruna Jangam, Lekhika Naik, Bala Manikanta Adimoolam, Suresh Vavilapalli, Sayanna Are, Jagadeshwar Reddy Thota, Surender Singh Jadav, Mohammed Arifuddin, Anthony Addlagatta |
| 44 |
[GO] |
2023―Apr―28 |
GMI, a fungal immunomodulatory protein, ameliorates SARS-CoV-2 envelope protein-induced inflammation in macrophages via inhibition of MAPK pathway |
Zhi-Hu Lin, Hsin Yeh, Hung-Chih Lo, Wei-Jyun Hua, Ming-Yang Ni, Li-Kai Wang, Ting-Ting Chang, Muh-Hwa Yang, Tung-Yi Lin |
| 45 |
[GO] |
2023―Apr―11 |
Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry |
Zhiwei Yang, Xinyue Fu, Yizhen Zhao, Xuhua Li, Jiangang Long, Lei Zhang |
| 46 |
[GO] |
2023―Mar―29 |
Preparation of a new monoclonal antibody against nucleocapsid protein of swine acute diarrhea syndrome coronavirus and identification of its linear antigenic epitope |
Xiao Cong, Lin Zhang, Haibo Zhu, Miaoli Wu, Yujun Zhu, Yuexiao Lian, Bihong Huang, Youfang Gu, Feng Cong |
| 47 |
[GO] |
2023―Mar―28 |
Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches |
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Naveed, Muhammad Shahbaz Aslam, Khyber Shinwari, Munir Ahmad Bhinder, Muhammad Usman Ghani, Mahjabeen Saleem, Mohd Ashraf Rather, Ishtiyaq Ahmad, Adnan Amin |
| 48 |
[GO] |
2023―Mar―10 |
Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines |
Dongliang Wang, Youqing Yuan, Bin Liu, Neal D. Epstein, Yi Yang |
| 49 |
[GO] |
2023―Feb―16 |
Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine |
Danping Zhao, Xiuhong Chen, Linyuan Wang, Jianjun Zhang, Zhongpeng Zhao, Na Yue, Yingli Zhu, Wenting Fei, Xinyu Li, Lingyun Tan, Wei He |
| 50 |
[GO] |
2023―Feb―03 |
Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays |
A. Mateen Khan, Saba Farooq, M. Iqbal Choudhary |
| 51 |
[GO] |
2023―Jan―20 |
Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro |
Rimanshee Arya, Vishal Prashar, Mukesh Kumar |
| 52 |
[GO] |
2023―Jan―09 |
Proteomic screening identifies RPLp2 as a specific regulator for the translation of coronavirus |
Hui-Jun Dong, Jing Wang, Xiu-Zhong Zhang, Cui-Cui Li, Jian-Feng Liu, Xiao-Jia Wang |
| 53 |
[GO] |
2022―Dec―30 |
Inhibitory effects of fucoidan from Laminaria japonica against some pathogenic bacteria and SARS-CoV-2 depend on its large molecular weight |
Xiaona Sun, Chunqing Ai, Chengrong Wen, Haoran Peng, Jingfeng Yang, Yuna Cui, Shuang Song |
| 54 |
[GO] |
2022―Dec―29 |
Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update |
Manojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee, Chiranjib Chakraborty |
| 55 |
[GO] |
2022―Dec―28 |
Major royal jelly proteins elicited suppression of SARS-CoV-2 entry and replication with halting lung injury |
Marwa M. Abu-Serie, Noha H. Habashy |
| 56 |
[GO] |
2022―Dec―14 |
SARS-CoV-2 RdRp uses NDPs as a substrate and is able to incorporate NHC into RNA from diphosphate form molnupiravir |
Maofeng Wang, Cancan Wu, Nan Liu, Fengyu Zhang, Hongjie Dong, Shuai Wang, Min Chen, Xiaoqiong Jiang, Kundi Zhang, Lichuan Gu |
| 57 |
[GO] |
2022―Dec―14 |
Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2 |
Bo Wang, Hua Xu, Zi-teng Liang, Tian-ning Zhao, Xin Zhang, Tian-bo Peng, You-chun Wang, Xiao-dong Su |
| 58 |
[GO] |
2022―Dec―14 |
Non-anticoagulant heparin derivatives for COVID-19 treatment |
Min Cao, Meng Qiao, Muhammad Sohail, Xing Zhang |
| 59 |
[GO] |
2022―Dec―12 |
Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay |
Yusen Xiang, Guanglei Zhai, Yaozong Li, Mengge Wang, Xixiang Chen, Ruyu Wang, Hang Xie, Weidong Zhang, Guangbo Ge, Qian Zhang, Yechun Xu, Amedeo Caflisch, Jianrong Xu, Hongzhuan Chen, Lili Chen |
| 60 |
[GO] |
2022―Dec―05 |
Inhibitory activities of alginate phosphate and sulfate derivatives against SARS-CoV-2 in vitro |
Cheng Yang, Dan Li, Shixin Wang, Meijie Xu, Dingfu Wang, Xin Li, Ximing Xu, Chunxia Li |
| 61 |
[GO] |
2022―Nov―24 |
Structural evolution of Delta lineage of SARS-CoV-2 |
Mohammad Mahmoudi Gomari, Parastoo Tarighi, Edris Choupani, Shadi Abkhiz, Masoud Mohamadzadeh, Neda Rostami, Esmaeil Sadroddiny, Soukayna Baammi, Vladimir N. Uversky, Nikolay V. Dokholyan |
| 62 |
[GO] |
2022―Oct―08 |
Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity |
Mario Cano-Muñoz, Daniel Polo-Megías, Ana Cámara-Artigas, José A. Gavira, María J. López-Rodríguez, Géraldine Laumond, Sylvie Schmidt, Julien Demiselle, Seiamak Bahram, Christiane Moog, Francisco Conejero-Lara |
| 63 |
[GO] |
2022―Oct―05 |
The inhibitory activity of methoxyl flavonoids derived from Inula britannica flowers on SARS-CoV-2 3CLpro |
Jang Hoon Kim, Yea-In Park, Mok Hur, Woo Tae Park, Youn-Ho Moon, Sung-Cheol Koo, Ik Soo Lee, Junsoo Park |
| 64 |
[GO] |
2022―Sep―29 |
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases |
Otávio Augusto Chaves, Carlyle Ribeiro Lima, Natalia Fintelman-Rodrigues, Carolina Q. Sacramento, Caroline S. de Freitas, Leonardo Vazquez, Jairo R. Temerozo, Marco E.N. Rocha, Suelen S.G. Dias, Nicolas Carels, Patrícia T. Bozza, Hugo Caire Castro-Faria-Neto, Thiago Moreno L. Souza |
| 65 |
[GO] |
2022―Sep―26 |
Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin |
Sk. Sarif Hassan, Vaishnavi Kodakandla, Elrashdy M. Redwan, Kenneth Lundstrom, Pabitra Pal Choudhury, Ángel Serrano-Aroca, Gajendra Kumar Azad, Alaa A.A. Aljabali, Giorgio Palu, Tarek Mohamed Abd El-Aziz, Debmalya Barh, Bruce D. Uhal, Parise Adadi, Kazuo Takayama, Nicolas G. Bazan, Murtaza Tambuwala, Samendra P. Sherchan, Amos Lal, Gaurav Chauhan, Wagner Baetas-da-Cruz, Vladimir N. Uversky |
| 66 |
[GO] |
2022―Sep―22 |
Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance |
Hanieh Shirvani, Hanieh Jafari, Sayyed Sajjad Moravveji, Fatemeh Abbasi Faranghizadeh, Mehrdad Talebi, Jalaledin Ghanavi, Farbod Esfandi, Sajad Najafi, Masomeh Nasiri Moghadam, Poopak Farnia, Seyed Mohsen Aghaei Zarch |
| 67 |
[GO] |
2022―Sep―21 |
A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan |
Yunxia He, Weili Yu, Lijuan Shen, Wenying Yan, Lucheng Xiao, Jinming Qi, Tao Hu |
| 68 |
[GO] |
2022―Sep―18 |
Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review |
Li-Yan Zhai, Ai-Min Su, Jing-Fan Liu, Jian-Jin Zhao, Xu-Guang Xi, Xi-Miao Hou |
| 69 |
[GO] |
2022―Sep―03 |
Unfolding of the SARS-CoV-2 spike protein through infrared and ultraviolet-C radiation based disinfection |
Nilkamal Mahanta, Swati Sharma, Laipubam Gayatri Sharma, Lalit M. Pandey, Uday Shanker Dixit |
| 70 |
[GO] |
2022―Jul―28 |
The SARS-CoV-2 targeted human RNA binding proteins network biology to investigate COVID-19 associated manifestations |
Kartikay Prasad, Pratibha Gour, Saurabh Raghuvanshi, Vijay Kumar |
| 71 |
[GO] |
2022―Jul―13 |
An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD) |
Dwipanjan Sanyal, Suharto Banerjee, Aritra Bej, Vaidehi Roy Chowdhury, Vladimir N. Uversky, Sourav Chowdhury, Krishnananda Chattopadhyay |
| 72 |
[GO] |
2022―Jun―08 |
Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus |
Claudia Almendárez-Rodriguez, Karla I. Solis-Andrade, Dania O. Govea-Alonso, Mauricio Comas-Garcia, Sergio Rosales-Mendoza |
| 73 |
[GO] |
2022―Apr―23 |
Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach |
Ritika Khatri, Hilal Ahmad Parray, Ashish Kumar Agrahari, Zaigham Abbas Rizvi, Rachel Kaul, Sneha Raj, Shailendra Asthana, Shailendra Mani, Sweety Samal, Amit Awasthi, Shubbir Ahmed |
| 74 |
[GO] |
2022―Apr―20 |
Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2 |
Tingting Li, Bingjie Zhou, Yaning Li, Suqiong Huang, Zhipu Luo, Yuanze Zhou, Yanling Lai, Anupriya Gautam, Salome Bourgeau, Shurui Wang, Juan Bao, Jingquan Tan, Dimitri Lavillette, Dianfan Li |
| 75 |
[GO] |
2022―Apr―19 |
Expression, purification, and biophysical characterization of recombinant MERS-CoV main (Mpro) protease |
Ghada Obeid Almutairi, Ajamaluddin Malik, Mona Alonazi, Javed Masood Khan, Abdullah S. Alhomida, Mohd Shahnawaz Khan, Amal M. Alenad, Nojood Altwaijry, Nouf Omar Alafaleq |
| 76 |
[GO] |
2022―Mar―26 |
Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses |
Yishan Fu, Fei Pan, Lei Zhao, Shuai Zhao, Junjie Yi, Shengbao Cai |
| 77 |
[GO] |
2022―Mar―16 |
An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19 |
Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, Kelvin Adrah, Mohammad Ali Daneshmehr |
| 78 |
[GO] |
2022―Mar―15 |
The spike glycoproteins of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape |
Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, Izabelle R. Farias, Mônica O. Belém, Yago O. Pinto, Heline H.T. Moreira, Ilana C.L. Magalhaes, Débora S.C.M. Castelo-Branco, Raquel C. Montenegro, Claudia R. de Andrade |
| 79 |
[GO] |
2022―Feb―08 |
Human SARS-CoV-2 has evolved to increase U content and reduce genome size |
Yong Wang, Xin-Yu Chen, Liu Yang, Qin Yao, K.P. Chen |
| 80 |
[GO] |
2022―Jan―22 |
Three wave changes, new variant strains, and vaccination effect against COVID-19 pandemic |
Rehan M. El-Shabasy, Mohamed A. Nayel, Mohamed M. Taher, Rehab Abdelmonem, Kamel R. Shoueir, El Refaie Kenawy |
| 81 |
[GO] |
2022―Jan―22 |
Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids |
Icaro Putinhon Caruso, Vitor dos Santos Almeida, Mariana Juliani do Amaral, Guilherme Caldas de Andrade, Gabriela Rocha de Araújo, Talita Stelling de Araújo, Jéssica Moreira de Azevedo, Glauce Moreno Barbosa, Leonardo Bartkevihi, Peter Reis Bezerra, Katia Maria dos Santos Cabral, Isabella Otênio de Lourenço, Clara L.F. Malizia-Motta, Aline de Luna Marques, Nathane Cunha Mebus-Antunes, Thais Cristtina Neves-Martins, Jéssica Maróstica de Sá, Karoline Sanches, Marcos Caique Santana-Silva, Ariana Azevedo Vasconcelos, Marcius da Silva Almeida, Gisele Cardoso de Amorim, Cristiane Dinis Anobom, Andrea T. Da Poian, Francisco Gomes-Neto, Anderson S. Pinheiro, Fabio C.L. Almeida |
| 82 |
[GO] |
2022―Jan―20 |
Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic |
Wan Lu, Zhuangzhuang Zhao, Yao-Wei Huang, Bin Wang |
| 83 |
[GO] |
2022―Jan―19 |
The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data |
Abbas Khan, Hira Waris, Memoona Rafique, Muhammad Suleman, Anwar Mohammad, Syed Shujait Ali, Taimoor Khan, Yasir Waheed, Chenguang Liao, Dong-Qing Wei |
| 84 |
[GO] |
2022―Jan―17 |
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19 |
Wajihul Hasan Khan, Nida Khan, Avinash Mishra, Surbhi Gupta, Vikrant Bansode, Deepa Mehta, Rahul Bhambure, M. Ahmad Ansari, Shukla Das, Anurag S. Rathore |
| 85 |
[GO] |
2021―Dec―28 |
Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment |
Nemany A.N. Hanafy, Maged A. El-Kemary |
| 86 |
[GO] |
2021―Dec―23 |
Is amyloid fibrillation related to 3D domain swapping for the C-terminal domain of SARS-CoV main protease? |
Zhiliang Yuan, Zhi Qu, Bo Duan, Tianyi Wang, Jiajun Xu, Bin Xia |
| 87 |
[GO] |
2021―Dec―04 |
Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies |
Pan Wang, Peiyang Ding, Qiang Wei, Aiping Wang, Hongliang Liu, Yunchao Liu, Qingmei Li, Yunrui Xing, Ge Li, Enmin Zhou, Gaiping Zhang |
| 88 |
[GO] |
2021―Dec―02 |
Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function |
Sk. Sarif Hassan, Kenneth Lundstrom, Ángel Serrano-Aroca, Parise Adadi, Alaa A.A. Aljabali, Elrashdy M. Redwan, Amos Lal, Ramesh Kandimalla, Tarek Mohamed Abd El-Aziz, Pabitra Pal Choudhury, Gajendra Kumar Azad, Samendra P. Sherchan, Gaurav Chauhan, Murtaza Tambuwala, Kazuo Takayama, Debmalya Barh, Giorgio Palu, Pallab Basu, Vladimir N. Uversky |
| 89 |
[GO] |
2021―Nov―24 |
Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome |
Salem A. El-aarag, Amal Mahmoud, Mahmoud ElHefnawi |
| 90 |
[GO] |
2021―Nov―12 |
COVID-19 diagnosis: current and future techniques |
Aarjoo Sharma, Sanjeev Balda, Mansi Apreja, Kirti Kataria, Neena Capalash, Prince Sharma |
| 91 |
[GO] |
2021―Nov―11 |
Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice |
Hui-Tsu Lin, Cheng-cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-an Chen, Jenn-jong Young, Szu-Cheng Kuo |
| 92 |
[GO] |
2021―Nov―11 |
Structural and functional significance of the amino acid differences Val35Thr, Ser46Ala, Asn65Ser, and Ala94Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV |
Alexander I. Denesyuk, Eugene A. Permyakov, Mark S. Johnson, Sergei E. Permyakov, Konstantin Denessiouk, Vladimir N. Uversky |
| 93 |
[GO] |
2021―Oct―31 |
Immunology and controlling of coronaviruses; the current enemy for humanity: A review |
Sarah I. Othman, Mohamed A. Nayel, Maha Abdulla Alwaele, Haifa Al Fassam, Gasem Mohammad Abu-Taweel, Naif Ghazi Altoom, Ahmed M. Almalki, Ahmed A. Allam, Asma M. Alturki, Rehan M. El-Shabasy |
| 94 |
[GO] |
2021―Oct―29 |
SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate |
Yi Zheng, Jinxiang Zhao, Jiaqi Li, Zhimou Guo, Jiajing Sheng, Xianlong Ye, Gaowa Jin, Chaoran Wang, Wengang Chai, Jingyu Yan, Dong Liu, Xinmiao Liang |
| 95 |
[GO] |
2021―Oct―28 |
SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review |
Jahangir Emrani, Maryam Ahmed, Robert H. Newman, Misty D. Thomas, Nathan Mowa, Liesl JeffersFrancis, John C. Teleha |
| 96 |
[GO] |
2021―Oct―25 |
COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks |
Chandran Murugan, Sharmiladevi Ramamoorthy, Kuppuswamy Guruprasad, Rajesh Kumar Murugan, Yuvaraj Sivalingam, Anandhakumar Sundaramurthy |
| 97 |
[GO] |
2021―Oct―18 |
Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19 |
Gulam Rabbani, Saeyoung Nate Ahn |
| 98 |
[GO] |
2021―Oct―15 |
State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? |
Bhargab Kalita, Anthony J. Saviola, Stephen P. Samuel, Ashis K. Mukherjee |
| 99 |
[GO] |
2021―Sep―27 |
Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2 |
Sushil Pokhrel, Thamer A. Bouback, Abdus Samad, Suza Mohammad Nur, Rahat Alam, Md. Abdullah-Al-Mamun, Zulkar Nain, Raihan Rahman Imon, Md. Enamul Kabir Talukder, Md. Mohaimenul Islam Tareq, Md Saddam Hossen, Tomasz M. Karpiński, Foysal Ahammad, Ishtiaq Qadri, Md. Shahedur Rahman |
| 100 |
[GO] |
2021―Sep―24 |
Implications derived from S-protein variants of SARS-CoV-2 from six continents |
Sk. Sarif Hassan, Kenneth Lundstrom, Debmalya Barh, Raner Jośe Santana Silva, Bruno Silva Andrade, Vasco Azevedo, Pabitra Pal Choudhury, Giorgio Palu, Bruce D. Uhal, Ramesh Kandimalla, Murat Seyran, Amos Lal, Samendra P. Sherchan, Gajendra Kumar Azad, Alaa A.A. Aljabali, Adam M. Brufsky, Ángel Serrano-Aroca, Parise Adadi, Tarek Mohamed Abd El-Aziz, Elrashdy M. Redwan, Kazuo Takayama, Nima Rezaei, Murtaza Tambuwala, Vladimir N. Uversky |
| 101 |
[GO] |
2021―Sep―10 |
Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation |
Nemat Ali, Kartikay Prasad, Abdullah F. AlAsmari, Metab Alharbi, Summya Rashid, Vijay Kumar |
| 102 |
[GO] |
2021―Sep―07 |
Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2 |
Letian Li, Maopeng Wang, Jiayi Hao, Jicheng Han, Tingting Fu, Jieying Bai, Mingyao Tian, Ningyi Jin, Guangze Zhu, Chang Li |
| 103 |
[GO] |
2021―Aug―18 |
Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach |
Mehrnaz Ebrahimi, Parviz Norouzi, Hossein Aazami, Ali Akbar Moosavi-Movahedi |
| 104 |
[GO] |
2021―Aug―14 |
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review |
Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, Şükran Köse, Mehdi Yousefi, Hossein Samadi Kafil |
| 105 |
[GO] |
2021―Aug―06 |
Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease |
Yunxia Xu, Ke Chen, Juanli Pan, Yingshou Lei, Danting Zhang, Lipei Fang, Jinle Tang, Xin Chen, Yanhong Ma, Yi Zheng, Bao Zhang, Yaoqi Zhou, Jian Zhan, Wei Xu |
| 106 |
[GO] |
2021―Aug―06 |
The method utilized to purify the SARS-CoV-2 N protein can affect its molecular properties |
Aneta Tarczewska, Marta Kolonko-Adamska, Mirosław Zarębski, Jurek Dobrucki, Andrzej Ożyhar, Beata Greb-Markiewicz |
| 107 |
[GO] |
2021―Jul―30 |
Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms |
Yuan Xiong, Guang-Hao Zhu, Ya-Ni Zhang, Qing Hu, Hao-Nan Wang, Hao-Nan Yu, Xiao-Ya Qin, Xiao-Qing Guan, Yan-Wei Xiang, Hui Tang, Guang-Bo Ge |
| 108 |
[GO] |
2021―Jul―27 |
Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus |
Chandrima Modak, Anubhuti Jha, Nivya Sharma, Awanish Kumar |
| 109 |
[GO] |
2021―Jul―05 |
Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2 |
Pravas Kumar Baral, Jiang Yin, Michael N.G. James |
| 110 |
[GO] |
2021―Jun―07 |
A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2) |
Mao-Sen Zeng, Wen-Di Yu, Hui-Xian Wang, Jin-Yuan Liu, Pei-Ping Xu |
| 111 |
[GO] |
2021―May―26 |
Ethyl cellulose coated sustained release aspirin spherules for treating COVID-19: DOE led rapid optimization using arbitrary interface; applicable for emergency situations |
T. Sreejith, Kaladhar Kamalasanan, Ashna Moidu, Pooja Shyamsundar, Shanti V. Nair, Lakshmi J. Nair, P. Venkatesan |
| 112 |
[GO] |
2021―May―25 |
Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review |
Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain |
| 113 |
[GO] |
2021―Apr―27 |
Chitin and chitosan as tools to combat COVID-19: A triple approach |
Mehrnoush Safarzadeh, Sahar Sadeghi, Mahdieh Azizi, Mohsen Rastegari-Pouyani, Ramin Pouriran, Mostafa Haji Molla Hoseini |
| 114 |
[GO] |
2021―Apr―26 |
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy |
Yash Gupta, Dawid Maciorowski, Samantha E. Zak, Chandrashekhar V. Kulkarni, Andrew S. Herbert, Ravi Durvasula, Jawed Fareed, John M. Dye, Prakasha Kempaiah |
| 115 |
[GO] |
2021―Apr―24 |
Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro |
Ruyu Wang, Qing Hu, Haonan Wang, Guanghao Zhu, Mengge Wang, Qian Zhang, Yishu Zhao, Chunyu Li, Yani Zhang, Guangbo Ge, Hongzhuan Chen, Lili Chen |
| 116 |
[GO] |
2021―Apr―21 |
Preparation of cellulose based wipes treated with antimicrobial and antiviral silver nanoparticles as novel effective high-performance coronavirus fighter |
Tamer Hamouda, Hassan M. Ibrahim, H.H. Kafafy, H.M. Mashaly, Nasser H. Mohamed, Nermin M. Aly |
| 117 |
[GO] |
2021―Apr―16 |
Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 |
Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Vladimir N. Uversky, Alaa A.A. Aljabali, Kenneth Lundstrom, Bruce D. Uhal, Nima Rezaei, Murat Seyran, Damiano Pizzol, Parise Adadi, Antonio Soares, Tarek Mohamed Abd El-Aziz, Ramesh Kandimalla, Murtaza M. Tambuwala, Gajendra Kumar Azad, Samendra P. Sherchan, Wagner Baetas-da-Cruz, Amos Lal, Giorgio Palé, Kazuo Takayama, Ángel Serrano-Aroca, Debmalya Barh, Adam M. Brufsky |
| 118 |
[GO] |
2021―Mar―29 |
A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients |
Ipsita Kumar Sen, Indranil Chakraborty, Amit Kumar Mandal, Sunil Kumar Bhanja, Sukesh Patra, Prasenjit Maity |
| 119 |
[GO] |
2021―Mar―23 |
A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase |
Suliman Khan, Farnoosh Attar, Samir Haj Bloukh, Majid Sharifi, Faisal Nabi, Qian Bai, Rizwan Hasan Khan, Mojtaba Falahati |
| 120 |
[GO] |
2021―Mar―12 |
Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic |
Nairah Noor, Adil Gani, Asir Gani, Asima Shah, Zanoor ul Ashraf |
| 121 |
[GO] |
2021―Mar―02 |
The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play |
Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, Izabelle R. Farias, Luina B. Lima, Raquel C. Montenegro |
| 122 |
[GO] |
2021―Mar―01 |
SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development |
Mandeep Kaur, Akanksha Sharma, Santosh Kumar, Gurpal Singh, Ravi P. Barnwal |
| 123 |
[GO] |
2021―Feb―17 |
Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2? |
Nivya Sharma, Chandrima Modak, Pankaj Kumar Singh, Rahul Kumar, Dharmender Khatri, Shashi Bala Singh |
| 124 |
[GO] |
2021―Feb―11 |
COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study |
Shima Parsa, Vahid Mogharab, Mohsen Ebrahimi, Sayyed Reza Ahmadi, Behzad Shahi, Neema John Mehramiz, Mahdi Foroughian, Mohammad Zarenezhad, Navid Kalani, Mohammad Hashem Abdi, Farshid Javdani, Pouyan Keshavarz, Naser Hatami |
| 125 |
[GO] |
2021―Feb―09 |
Potential drug targets of SARS-CoV-2: From genomics to therapeutics |
Anas Shamsi, Taj Mohammad, Saleha Anwar, Samreen Amani, Mohd Shahnawaz Khan, Fohad Mabood Husain, Md. Tabish Rehman, Asimul Islam, Md Imtaiyaz Hassan |
| 126 |
[GO] |
2021―Feb―05 |
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 |
Ashuai Du, Rong Zheng, Cyrollah Disoma, Shiqin Li, Zongpeng Chen, Sijia Li, Pinjia Liu, Yuzheng Zhou, Yilun Shen, Sixu Liu, Yongxing Zhang, Zijun Dong, Qinglong Yang, Moyed Alsaadawe, Aroona Razzaq, Yuyang Peng, Xuan Chen, Liqiang Hu, Jian Peng, Qianjun Zhang, Taijiao Jiang, Long Mo, Shanni Li, Zanxian Xia |
| 127 |
[GO] |
2021―Feb―05 |
Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein |
Shruti Mukherjee, Amaravadhi Harikishore, Anirban Bhunia |
| 128 |
[GO] |
2021―Jan―11 |
SARS-Cov-2 ORF3a: Mutability and function |
Martina Bianchi, Alessandra Borsetti, Massimo Ciccozzi, Stefano Pascarella |
| 129 |
[GO] |
2020―Dec―29 |
Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study |
Shreya Bhattacharya, Arundhati Banerjee, Sujay Ray |
| 130 |
[GO] |
2020―Dec―09 |
Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs |
Naveen Narayanan, Deepak T. Nair |
| 131 |
[GO] |
2020―Dec―06 |
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches |
Vinit Raj, Jae Gyu Park, Kiu-Hyung Cho, Pilju Choi, Taejung Kim, Jungyeob Ham, Jintae Lee |
| 132 |
[GO] |
2020―Sep―28 |
Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials |
Fatemeh Oroojalian, Ali Haghbin, Behzad Baradaran, Nima Hemmat, Mohammad-Ali Shahbazi, Hossein Bannazadeh Baghi, Ahad Mokhtarzadeh, Michael R. Hamblin |
| 133 |
[GO] |
2020―Sep―24 |
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13) |
Osman Mutluhan Ugurel, Ozal Mutlu, Emrah Sariyer, Sinem Kocer, Erennur Ugurel, Tugba Gul Inci, Oguz Ata, Dilek Turgut-Balik |
| 134 |
[GO] |
2020―Sep―24 |
The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica |
Weihua Jin, Wenjing Zhang, Dipanwita Mitra, Martin G. McCandless, Poonam Sharma, Ritesh Tandon, Fuming Zhang, Robert J. Linhardt |
| 135 |
[GO] |
2020―Sep―17 |
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach |
Md. Sorwer Alam Parvez, Md. Adnan Karim, Mahmudul Hasan, Jomana Jaman, Ziaul Karim, Tohura Tahsin, Md. Nazmul Hasan, Mohammad Jakir Hosen |
| 136 |
[GO] |
2020―Aug―24 |
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2 |
Praveen Kumar Tripathi, Saurabh Upadhyay, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Pradeep Sharma, Ashok Kumar Patel |
| 137 |
[GO] |
2020―Aug―01 |
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening |
Olga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T. Reyburn, Bruno Rizzuti, Adrian Velazquez-Campoy |
| 138 |
[GO] |
2020―Jul―18 |
A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor |
Pedro F.N. Souza, Francisco E.S. Lopes, Jackson L. Amaral, Cleverson D.T. Freitas, Jose T.A. Oliveira |
| 139 |
[GO] |
2020―Jul―15 |
Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach |
Samira Sanami, Milad Zandi, Behzad Pourhossein, Gholam-Reza Mobini, Mohsen Safaei, Atena Abed, Pooria Mohammadi Arvejeh, Fatemeh Amini Chermahini, Morteza Alizadeh |
| 140 |
[GO] |
2020―Jul―14 |
Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines |
Xiangyan Chen, Wenwei Han, Guixiang Wang, Xia Zhao |
| 141 |
[GO] |
2020―Jun―26 |
Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective |
Kartikay Prasad, Fatima Khatoon, Summya Rashid, Nemat Ali, Abdullah F. AlAsmari, Mohammad Z. Ahmed, Ali S. Alqahtani, Mohammed S. Alqahtani, Vijay Kumar |
| 142 |
[GO] |
2020―Jun―26 |
Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach |
Ishtiaque Ahammad, Samia Sultana Lira |
| 143 |
[GO] |
2020―May―30 |
A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2 |
Maopeng Wang, Tingting Fu, Jiayi Hao, Letian Li, Mingyao Tian, Ningyi Jin, Linzhu Ren, Chang Li |
| 144 |
[GO] |
2020―May―26 |
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment |
Biswajit Naik, Nidhi Gupta, Rupal Ojha, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty |
| 145 |
[GO] |
2019―Dec―02 |
Construction and optimization of Lactobacillus plantarum expression system expressing glycoprotein 5 of porcine reproductive and respiratory syndrome virus |
Maopeng Wang, Shouwen Du, Wang Xu, Lina Song, Pengfei Hao, Ningyi Jin, Linzhu Ren, Chang Li |
|
